AAAAAA

   
Results: 1-16 |
Results: 16

Authors: LAAKSO J MERVAALA E HIMBERG JJ TERAVAINEN TL KARPPANEN H VAPAATALO H LAPATTO R
Citation: J. Laakso et al., INCREASED KIDNEY XANTHINE OXIDOREDUCTASE ACTIVITY IN SALT-INDUCED EXPERIMENTAL-HYPERTENSION, Hypertension, 32(5), 1998, pp. 902-906

Authors: LINKO S HIMBERG JJ THIENPONT L STOCKL D DELEENHEER A
Citation: S. Linko et al., ASSESSMENT OF THE STATE-OF-THE-ART TRUENESS AND PRECISION OF SERUM TOTAL-CALCIUM AND GLUCOSE MEASUREMENTS IN FINNISH LABORATORIES - THE QSL-FINLAND STUDY, Scandinavian journal of clinical & laboratory investigation, 58(3), 1998, pp. 229-239

Authors: ABERG L HEISKALA H VANHANEN SL HIMBERG JJ HOSKING G YUEN A SANTAVUORI P
Citation: L. Aberg et al., LAMOTRIGINE THERAPY IN INFANTILE NEURONAL CEROID-LIPOFUSCINOSIS (INCL), Neuropediatrics, 28(1), 1997, pp. 77-79

Authors: WATSON I POTTER J YATSCOFF R FRASER A HIMBERG JJ WENK M
Citation: I. Watson et al., UNTITLED, Therapeutic drug monitoring, 19(2), 1997, pp. 125-125

Authors: KARILA T LAAKSONEN R JOKELAINEN K HIMBERG JJ SEPPALA T
Citation: T. Karila et al., THE EFFECTS OF ANABOLIC-ANDROGENIC STEROIDS ON SERUM UBIQUINONE AND DOLICHOL LEVELS AMONG STEROID ABUSERS, Metabolism, clinical and experimental, 45(7), 1996, pp. 844-847

Authors: LAAKSONEN R JOKELAINEN K LAAKSO J SAHI T HARKONEN M TIKKANEN MJ HIMBERG JJ
Citation: R. Laaksonen et al., THE EFFECT OF SIMVASTATIN TREATMENT ON NATURAL ANTIOXIDANTS IN LOW-DENSITY LIPOPROTEINS AND HIGH-ENERGY PHOSPHATES AND UBIQUINONE IN SKELETAL-MUSCLE, The American journal of cardiology, 77(10), 1996, pp. 851-854

Authors: LAAKSONEN R FOGELHOLM M HIMBERG JJ LAAKSO J SALORINNE Y
Citation: R. Laaksonen et al., UBIQUINONE SUPPLEMENTATION AND EXERCISE CAPACITY IN TRAINED YOUNG ANDOLDER MEN, European journal of applied physiology and occupational physiology, 72(1-2), 1995, pp. 95-100

Authors: LAAKSONEN R RIIHIMAKI A LAITILA J MARTENSSON K TIKKANEN MJ HIMBERG JJ
Citation: R. Laaksonen et al., SERUM AND MUSCLE-TISSUE UBIQUINONE LEVELS IN HEALTHY-SUBJECTS, The Journal of laboratory and clinical medicine, 125(4), 1995, pp. 517-521

Authors: SANTAVUORI P HIMBERG JJ AHOLA A HOSKING G YUEN AWC
Citation: P. Santavuori et al., LAMOTRIGINE THERAPY IN INFANTILE NEURONAL CEROID-LIPOFUSCINOSIS, Epilepsia, 36, 1995, pp. 264-265

Authors: LAAKSONEN R JOKELAINEN K SAHI T TIKKANEN MJ HIMBERG JJ
Citation: R. Laaksonen et al., DECREASES IN SERUM UBIQUINONE CONCENTRATIONS DO NOT RESULT IN REDUCEDLEVELS IN MUSCLE-TISSUE DURING SHORT-TERM SIMVASTATIN TREATMENT IN HUMANS, Clinical pharmacology and therapeutics, 57(1), 1995, pp. 62-66

Authors: BACKMAN JT OLKKOLA KT ARANKO K HIMBERG JJ NEUVONEN PJ
Citation: Jt. Backman et al., DOSE OF MIDAZOLAM SHOULD BE REDUCED DURING DILTIAZEM AND VERAPAMIL TREATMENTS, British journal of clinical pharmacology, 37(3), 1994, pp. 221-225

Authors: KIRVELA O KATILA A AANTAA R KANTO J HIMBERG JJ
Citation: O. Kirvela et al., METABOLIC AND SUBJECTIVE RESPONSES TO ORAL DIAZEPAM AND MIDAZOLAM, European journal of anaesthesiology, 11(5), 1994, pp. 365-369

Authors: BACKMAN JT ARANKO K HIMBERG JJ OLKKOLA KT
Citation: Jt. Backman et al., A PHARMACOKINETIC INTERACTION BETWEEN ROXITHROMYCIN AND MIDAZOLAM, European Journal of Clinical Pharmacology, 46(6), 1994, pp. 551-555

Authors: LAAKSONEN R OJALA JP TIKKANEN MJ HIMBERG JJ
Citation: R. Laaksonen et al., SERUM UBIQUINONE CONCENTRATIONS AFTER SHORT-TERM AND LONG-TERM TREATMENT WITH HMG-COA REDUCTASE INHIBITORS, European Journal of Clinical Pharmacology, 46(4), 1994, pp. 313-317

Authors: FOGELHOLM M RUOKONEN I LAAKSO JT VUORIMAA T HIMBERG JJ
Citation: M. Fogelholm et al., LACK OF ASSOCIATION BETWEEN INDEXES OF VITAMIN-B(1) VITAMIN-B(2) AND VITAMIN-B(6) STATUS AND EXERCISE-INDUCED BLOOD LACTATE IN YOUNG-ADULTS, INT J SP NU, 3(2), 1993, pp. 165-176

Authors: FOGELHOLM GM HIMBERG JJ ALOPAEUS K GREF CG LAAKSO JT LEHTO JJ MUSSALORAUHAMAA H
Citation: Gm. Fogelholm et al., DIETARY AND BIOCHEMICAL INDEXES OF NUTRITIONAL-STATUS IN MALE-ATHLETES AND CONTROLS, Journal of the American College of Nutrition, 11(2), 1992, pp. 181-191
Risultati: 1-16 |